Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry (v3.6.6) appears in the study record history with updated status notes (e.g., Returned, Quality Control Review Has Not Concluded) and the addition of sections like Adverse Events, Outcome Measures (Results), and Participant Flow; the prior revision (v3.6.5) is removed from the history.
    Difference
    0.9%
    Check dated 2026-09-01T18:27:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    New latest revision v3.6.5 appears in the history, replacing the previous v3.6.4 and signaling an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-08-11T08:25:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added entries indicate the study record now includes Adverse Events, Baseline Characteristics, Participant Flow, and Outcome Measures (Results), along with the Study Status. The entry also notes that the submission was returned on 2026-07-29 with Quality Control Review not concluded.
    Difference
    0.9%
    Check dated 2026-08-04T08:35:55.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study history, and the previous revision v3.6.3 was removed from the visible history list, indicating an update to the record's metadata.
    Difference
    0.1%
    Check dated 2026-07-28T04:56:07.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry labeled v3.6.3, replacing the previous v3.6.2. This reflects an updated version of the record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-07-06T16:37:55.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The latest version returned on 2026-06-24 adds sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, Arms and Interventions, and Study Design to the history, and notes that Quality Control Review Has Not Concluded. This reflects expanded documentation in the study record and a current QC status for ongoing review.
    Difference
    1%
    Check dated 2026-06-29T08:35:03.000Z thumbnail image

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.